Track all markets on TradingView
Key Takeaways From Pfizer Analyst Ratings
Media

Key Takeaways From Pfizer Analyst Ratings

  • November 15, 2024
  • 7 Views

Latest Ratings for PFE

Date Firm Action From To
Feb 2022 Morgan Stanley Maintains Equal-Weight
Jan 2022 Wells Fargo Maintains Overweight
Jan 2022 B of A Securities Upgrades Neutral Buy

View More Analyst Ratings for PFE

View the Latest Analyst Ratings

read more

​ 

​Latest Ratings for PFE
DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsEqual-Weight Jan 2022Wells FargoMaintainsOverweight Jan 2022B of A SecuritiesUpgradesNeutralBuy
View More Analyst Ratings for PFE

View the Latest Analyst Ratings

read more 

Share This Post:

Leave a Reply

Your email address will not be published. Required fields are marked *

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.